Anti-inflammatory and antinociceptive activity of diphenyl diselenide

Inflammation Research

Volumn 52, Issue 2, 2003, Pages 56-63

  Nogueira, C W ^a   Quinhones, E B ^a   Jung, E A C ^a   Zeni, G ^a   Rocha, J B T ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Anti inflammatory; Antinociception; Diphenyl diselenide and ebselen

Indexed keywords

ACETIC ACID; ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; CAPSAICIN; CARRAGEENAN; DIPHENYLDISELENIDE; EBSELEN; FORMALDEHYDE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG ACTIVITY; GASTROINTESTINAL DISEASE; HUMAN; KIDNEY INJURY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PAIN; PAW EDEMA; RAT; RAT STRAIN; TAIL FLICK TEST; WRITHING TEST;

EID: 84984572868     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110300001     Document Type: Article

References (47)

1. st amino acid. Mol Microbiol 1991; 5: 515-20.
2. Flohé L, Gunzler WA, Shock HH. Glutathione peroxidase: A selenium enzyme. FEBS Lett 1973; 32: 132-4.
3. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoestra WG. Selenium: Biochemical role as a component of glutathione peroxidase. Science 1973; 179: 558-60.
4. Ursini F, Maiorino M, Valente M, Ferri KC. Purification of pig liver of a protein which protects lipossomes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxidase. Biochem Biophys Acta 1982; 710: 197-211.
5. Müller A, Gabriel H, Sies H. A novel biologically active selenoorganic compound-IV. Protective glutathione-dependent effect of PZ51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes. Biochem Pharmacology 1985; 34: 1185-9.
6. Wendel A, Fausel M, Safayi H, Otter R. A novel biologically active seleno-organic compound-II. Activity of PZ 51 in relation to glutathione peroxidase. Biochem Pharmacol 1984; 33: 3241-5.
7. 1-NMR method. J Am Chem Soc 1992; 114: 9737-43.
8. Rossato JI, Zeni G, Mello CF, Rubin MA, Rocha JBT. Ebselen blocks the quinolinic acid- induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Letts 2002a; 318: 137-41.
9. Rossato JI, Ketzer LA, Centurião FB, Silva SJN, Lüdtke DS, Zeni G, Braga AL, Rubin MA, Rocha JBT. Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem Res 2002b; 27: 297-303.
10. Parnham MJ, Graf E. Seleno-organic compounds and the therapy of hydroperoxide-linked pathological conditions. Biochem Pharmacol 1987; 36: 3095-102.
11. Sies H. Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radical Biology & Medicine 1993; 14: 313-23.
12. Schewe T. Molecular actions of Ebselen - An antiinflammatory antioxidant. Gen Pharmacol 1995; 26: 1153-69.
13. Sies H, Arteel GE. Interaction of peroxynitrite with selenoprotein-sand glutathione peroxidase mimics. Free Radic Biol Med 2000; 28: 1451-5.
14. Parnham MJ, Graf E. Pharmacology of synthetic organic selenium compounds. Prog Drug Res 1991; 36: 9-47.
15. Cotgreave IA, Duddy SK, Kass GEN, Thompson D, Moldeus P. Studies on the anti-inflammatory activity of Ebselen. Ebselen interferes with granulocyte oxidative burst by dual inhibition of NADPH oxidase and protein kinase C? Biochem Pharmacol 1989; 38: 649-56.
16. Walther M, Holzhütter H, Kuban R J, Wiesner R, Rathmann J, Kühn H. The inhibition of mammalian 15-lipoxygenase by the anti-inflammatory drug Ebselen: Dual type mechanism involving covalent linkage and alteration of the iron ligand sphere. J Pharmac Exp Therap 1999; 56: 196-203.
17. Mugesh G, du Mont WW, Sies H. Chemistry of biologically important organoselenium compounds. Chem Rev 2001; 101: 2125-79.
18. Yamagushi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H. Ebselen in acute ischemic stroke: A placebo-controlled, doublé-blind clinical trial. Stroke 1998; 29: 12-7.
19. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi Y. Neuroprotective effect of an antioxidant, Ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 1998; 42: 269-77.
20. Comasseto JV, Menezes PH, Stefani HA, Zeni G, Braga AL. Addition of hydrogen halides to acetylenic selenides. Synthesis of 1-halo-1-selenoalkenes. Tetrahedron 1996; 52: 9687-702.
21. Braga AL, Zeni G, Andrade LH, Silveira CC. Stereoconservative formation and reactivity of α-chalcogen-funcionalized vinyllithium compounds from α-bromo-vinylic chalcogenides. Synlett 1997; 5: 595-6.
22. Braga AL, Zeni G, Andrade LH, Silveira CC, Stefani HA. Stereo-specific formation of chalcogenoenynes via palladium catalysed cross-coupling reaction of α-bromovinylic chalcogenides. Synthesys 1988; 1: 39-41.
23. Wilson SR, Zucker PA, Huang R-RC, Spector A. Development of synthetic compounds with glutathione peroxidase activity. J Am Chem Soc 1989; 111: 5936-9.
24. Barbosa NB, Rocha JBT, Zeni G, Emanuelli T, Beque MC, Braga AL. Effect of organic forms of selenium on δ-aminolevulinate dehydratase from liver, kidney and brain of adult rats. Toxicol Appl Pharmacol 1998; 149: 243-53.
25. Farina M, Barbosa NBV, Nogueira CW, Folmer V, Zeni G, Andrade LH, Braga AL, Rocha JBT. Reaction of diphenyl diselenide with hydrogen peroxide and inhibition of δ-Aminolevulinate dehydratase from rat liver and cucumber leaves. Brazilian J Med Biol Res 2002; 35: 623-31.
26. Engman L. Expedient synthesis of Ebselen and related compounds. J Org Chem 1989; 54: 2964-6.
27. Paulmier C. Selenoorganic functional groups. In: Paulmier C. Selenium reagents and intermediates in organic synthesis. 1 ed. Pergamon Press, Oxford 1986: 25-51.
28. Vendite D, Rocha JBT, Souza DO. Effects of undernutrition during suckling on novelty-induced analgesia in young and adult-rats. Physiol Behav 1990; 47: 393-5.
29. Winter CA, Reslev EA, Nuss GW. Carragenin-induced paw edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 1962; 111: 544-7.
30. Ahmadiani A, Javan M, Semnanian S, Barat E, Kamalinejad M. Anti-inflammatory and antipyretic effects of Trigonella foenumgraecum leaves extract in the rat. J Ethnopharmacol 2001; 75: 283-6.
31. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30: 103-14.
32. Shibata M, Ohkubo T, Takahashi H, Inoki R. Modified formalin test: characteristic biphasic response. Pain 1989; 38: 347-52.
33. Santos ARS, Miguel OG, Yunes RA, Calixto JB. Antinociceptive properties of the new alkaloid, cis-8,10-di-N-propyllobelidiol hydrochloride dihydrate isolated from Siphocampylus verticillatus: Evidence for the mechanism of action. J Exp Pharmacol Ther 1999; 289: 417-26.
34. 2 bradykinin receptor antagonist NPC 18688 in mice. Br J Pharmacol 1996; 117: 552-8.
35. Janssen PAJ, Niemegeers CJE, Dony JGH. The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats. Drug Res Arzneim Forsch 1963; 13: 502-7.
36. Di Rosa M, Giroud JP, Willoughby DA. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenin and turoentine. J Pathol 1971; 104: 15-29.
37. Ferreira SH, Lorenzetti BB, Correa FM. A Central and Peripheral antianalgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53: 39-48.
38. Safayhi H, Tiegs G, Wendel A. A novel biologically active seleno-organic compound-V. Inhibition by ebselen (PZ 51) of rat peritoneal neutrophil lipoxygenase. Biochem Pharmacol 1985; 34: 2691-4.
39. 4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans isomer. Prostaglandins 1986; 31: 1029-48.
40. Egan RW, Gale PH. Inhibition of mammalian 5-lypoxigenase by aromatic disulfides. J Biol Chem 1985; 21: 11554-9.
41. Young JM, Tomolonis AJ. Diphenyldisulphide inhibits indomethacin-induced ulcerogenesis in rats. Agents Actions 1987; 21: 314-5.
42. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
43. Dray A, Bettaney J, Forster P. Actions of capsaicin on peripheral nociceptors of the neonatal rat spinal cord-tail in vitro: dependence of extracellular ions and independence of second messengers. Br J Pharmacol 1990; 101: 727-33.
44. Bevan S, Hothi S, Hughes GA, James IF, Rang HP, Shah K, Walpole CSJ, Yeats, JC. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 1992; 107: 544-52.
45. Szallasi A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand 1995; 155: 1-68.
46. Santos ARS, Calixto JB. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice. Neurosci Letts 1997; 235: 73-6.
47. Collier HOJ, Dinnen LC, Johnson CA, Scheneider C. The abdominal constriction response and its suppression by analgesic drugs in mice. Br J Pharmacol 1968; 32: 295-310.